| Long name: |
C3/C3d, C3d (Complement C3d Fragment, CPAMD1), Complement Component 3, Complement Component C3d, Complement Factor 3, Complement C3 |
| Antigen: |
C3d, Complement C3 |
| Synonim names: |
C3/C3d, C3d (Complement C3d Fragment, CPAMD1), Complement Component 3, Complement Component C3d, Complement Factor 3, Anti -Complement C3 |
| Other names: |
ASP, Alternative name(s):, C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1, C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1Cleaved into the following 11 chains:Complement C3 beta chainComplement C3 alpha chainC3a anaphylatoxinAcylation stimulating protein, C3a anaphylatoxin, C3adesArg, Complement C3, acylation-stimulating protein cleavage product, complement C3, complement component 3, complement component C3, complement component C3a, complement component C3b, prepro-C3, complement C3 |
| Gene name: |
C3d, Complement C3 |
| Gene synonims: |
AHUS5, ARMD9, ASP, ASP, C3, C3a, C3b, CPAMD1, CPAMD1, C3 |
| Category: |
Antibodies |
| Clonality: |
Polyclonal Antibodies |
| Clone: |
Not applicable to Polyclonal Antibodies |
| Reacts with: |
Human (Homo sapiens) |
| Specificity: |
, Also reacts with fragments bearing common determinants: C3, C3b, C3bi, C3d, Does not react with any other proteins component of human serum or plasma, In immunoelectrophoresis and double radial immunodiffusion against normal human serum, In supernatants of serum containing 10% polyethyleneglycol only a reaction with C3d has been obtained, a single precipitin line is obtained and giving a reaction of full identity with the purified immunogen, Recognizes human C3d, This is an antibody designed to detect Complement C3 |
| Purification method: |
Serum Serum |
| Form/Appearance: |
Dilute further in PBS, Preservative free, Reconstitute with 1ml sterile ddH2O, pH 7, 2, Supplied as a lyophilized powder |
| Concentration: |
Enquire us for detailed information on the concentration of this antibody |
| Storage, shipping and handling: |
Aliquot to avoid repeated freezing and thawing, Avoid cycles of freezing and thawing as they may denaturate the polypeptide chains of the antibody, Due to transportation or handling reasons, For longer periods of time we recommend keeping the vial frozen at -40 or -80, Further dilutions can be made in assay buffer, Reconstitute with sterile ddH2O, Reconstituted product is stable for 12 months at -20 degree C, Stable for 12 months at -20 degree C, Store at -20 degree C, The antibody is shipped at +4 degrees Celsius, Upon receving, freeze at -20, small amounts of the antibody might get caught on the lid or walls of the vial, Lyophilized powder may be stored at -20 degree C |
| Applications: |
ELISA (EL/EIA) |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by MBS Polyclonals they should be stored frozen at - 24° |
| Gene target: |
C3d, Complement C3 |
| Short name: |
C3d Antibody, Anti- Complement C3 |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
C3d (Antibody to), Antibody to Complement complement component 3 |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
AHUS5 and ARMD9 and ASP and C3a and C3b and CPAMD1 and HEL-S-62p, BT, C3 and IDBG-193788 and ENSMUSG00000024164 and 102642251, C3 and IDBG-21798 and ENSG00000125730 and 718, C5L2 anaphylatoxin chemotactic receptor binding, Extracellular, alternative pathway and biological process this GO :0006958 and complement activation, classical pathway and biological process this GO :0007165 and signal transduction and biological process this GO :0007186 and G-protein coupled receptor signaling pathway and biological process this GO :0010575 and positive regulation vascular endothelial growth factor production and biological process this GO :0010828 and positive regulation of glucose transport and biological process this GO :0010866 and regulation of triglyceride biosynthetic process and biological process this GO :0010884 and positive regulation of lipid storage and biological process this GO :0010951 and negative regulation of endopeptidase activity and biological process this GO :0030449 and regulation of complement activation and biological process this GO :0031715 and C5L2 anaphylatoxin chemotactic receptor binding and molecular function this GO :0045087 and innate immune response and biological process this GO :0045745 and positive regulation of G-protein coupled receptor protein signaling pathway and biological process this GO :0045766 and positive regulation of angiogenesis and biological process this GO :0050766 and positive regulation of pha this GO cytosis and biological process this GO :0050776 and regulation of immune response and biological process this GO :0070062 and extracellular vesicular exosome and cellular component this GO :0072562 and blood microparticle and cellular component this GO :2000427 and positive regulation of apoptotic cell clearance and biological process, this GO :0001798 and positive regulation of type IIa hypersensitivity and biological process this GO :0001934 and positive regulation of protein phosphorylation and biological process this GO :0001970 and positive regulation of activation of membrane attack complex and biological process this GO :0004866 and endopeptidase inhibitor activity and molecular function this GO :0005102 and receptor binding and molecular function this GO :0005515 and protein binding and molecular function this GO :0005576 and extracellular region and cellular component this GO :0005615 and extracellular space and cellular component this GO :0005886 and plasma membrane and cellular component this GO :0006631 and fatty acid metabolic process and biological process this GO :0006954 and inflammatory response and biological process this GO :0006955 and immune response and biological process this GO :0006956 and complement activation and biological process this GO :0006957 and complement activation, this GO :0004866 : endopeptidase inhibitor activity, this GO :0004866 : endopeptidase inhibitor activity and also this GO :0005102 : receptor binding and also this GO :0005515 : protein binding and also this GO :0031715 : C5L2 anaphylatoxin chemotactic receptor binding, this GO :0005102 : receptor binding, this GO :0005515 : protein binding, this GO :0031715 : C5L2 anaphylatoxin chemotactic receptor binding, 12266, 19562 and IDBG-643930 and ENSBTAG00000017280 and 280677, complement component 3 |